4//SEC Filing
Bray June 4
Accession 0000912282-25-000613
CIK 0001662774other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:07 PM ET
Size
5.3 KB
Accession
0000912282-25-000613
Insider Transaction Report
Form 4
Bray June
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-04+27,000→ 27,000 totalExercise: $1.09Exp: 2035-06-04→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest 100% on the one-year anniversary of the grant date. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the issuer's Outside Director Compensation Policy.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001845487
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:07 PM ET
- Size
- 5.3 KB